Demand for lenacapavir is far outstripping supply in Uganda, other parts of Africa and all over the world. U.S. regulators on Monday approved a generic version for sale in low-income countries.
Demand for lenacapavir is far outstripping supply in Uganda, other parts of Africa and all over the world. U.S. regulators on Monday approved a generic version for sale in low-income countries.
<iframe src="https://statesidedaily.com/embed/cluster/d1687364c5297ceb5dc3fe6fef2f9d4c3b481e5b" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="A new HIV-prevention drug is showing promising signs, but it's difficult to find in Africa and beyond"></iframe>
